ScienceOpen:
research and publishing network
For Publishers
Discovery
Metadata
Peer review
Hosting
Publishing
For Researchers
Join
Publish
Review
Collect
My ScienceOpen
Sign in
Register
Dashboard
Blog
About
Search
Advanced search
My ScienceOpen
Sign in
Register
Dashboard
Search
Search
Advanced search
For Publishers
Discovery
Metadata
Peer review
Hosting
Publishing
For Researchers
Join
Publish
Review
Collect
Blog
About
3
views
0
references
Top references
cited by
1
0 reviews
Review
0
comments
Comment
0
recommends
+1
Recommend
0
collections
Add to
0
shares
Share
Twitter
Sina Weibo
Facebook
Email
1,977
similar
All similar
Record
: found
Abstract
: not found
Article
: not found
Treatment of insulin resistance syndrome and type 2 diabetes with PDE9 inhibitors.
Author(s):
DA Fryburg
,
EM Gibbs
Publication date:
2003
Read this article at
ScienceOpen
Bookmark
There is no author summary for this article yet. Authors can add summaries to their articles on ScienceOpen to make them more accessible to a non-specialist audience.
Related collections
Cures Within Reach: Autoimmune Lymphoproliferative Syndrome (ALPS)
Data availability:
Comments
Comment on this article
Sign in to comment
Similar content
1,977
The effects of the novel phosphodiesterase 9 (PDE9) inhibitor E2027 (irsenontrine) on CSF cGMP, additional CSF and plasma biomarkers, and clinical outcomes in amyloid positive and amyloid negative patients with dementia with Lewy bodies (DLB) and Parkinson's disease dementia (PDD)
Authors:
KP P. Sachdev
,
T Devins
,
L. Reyderman
A novel PDE9 inhibitor WYQ‐C36D ameliorates corticosterone‐induced neurotoxicity and depression‐like behaviors by cGMP‐CREB‐related signaling
Authors:
Xian-Feng Huang
,
Wen-Tao Jiang
,
Li Liu
…
Erratum: PDE9 inhibitor PF-04447943 attenuates DSS-induced colitis by suppressing oxidative stress, inflammation, and regulating T-cell polarization
Authors:
See all similar